NFKB1 and COVID-19: Of note, the NFkB (Nuclear factor kappa-light-chain-enhancer of activated B cells) pathway was also significantly upregulated following COVID-19 serum exposure indicating that, at least in part, the signalling cascade was driven via this route (Figure 5D and E).